Studi In Silico Senyawa Bioaktif Ekstrak Curcuma longa sebagai Inhibitor Protein LASR pada Bakteri Pseudomonas aeruginosa In Silico Study of Bioactive Compounds in Curcuma longa Extract as Inhibitors of the LASR Protein in Pseudomonas aeruginosa

Crossmark

Main Article Content


Abstract

Pseudomonas aeruginosa is an opportunistic pathogenic bacterium that employs a quorum-sensing mechanism mediated by the LasR protein to regulate biofilm formation and virulence. This study aims to analyze the potential of bioactive compounds from Curcuma longa as inhibitors of the LasR protein through an in silico approach. The study employed a computational approach using molecular docking to predict interactions between the ligands and the LasR protein. The analysis was followed by the prediction of physicochemical properties based on Lipinski’s Rule of Five and the evaluation of pharmacokinetic and toxicity profiles using ADMET parameters. The molecular docking results showed that all compounds had negative docking scores ranging from −6.9297 to −9.5288 kcal/mol. Curcumin and demethoxycurcumin exhibited the strongest binding affinities, with docking scores of −9.5288 and −9.5189 kcal/mol, respectively. All compounds met the criteria of Lipinski’s Rule of Five and demonstrated reasonably favorable ADMET profiles, although a moderate potential for toxicity was identified based on the AMES mutagenicity and human hepatotoxicity parameters. This study concludes that the bioactive compounds of Curcuma longa, particularly curcumin and demethoxycurcumin, have the potential to be developed as candidate inhibitors of the LasR protein. These findings provide a computational basis for compound structure optimization and further research through in vitro and in vivo testing to validate their effectiveness and safety as LasR inhibitors.

Keywords:
Share Article:

Citation Metrics:

Scopus

Downloads

Download data is not yet available.

Citation Metrics & Similar Scopus Articles

Citation data unavailable from the configured source
Check Secondary Documents in Scopus
Open this article in Scopus, then check the Secondary documents tab. Use Manual Citation Fallback only for counts you have verified manually.
Open in Scopus
Similar Scopus Articles
Scopus
  1. Aouachria S. (2027)
    Phytochemical Insights into Reichardia picroides L.: Luteolin-7-O-β-Glucoside Isolation, In Silico Analysis, and Bioactivity of Extract and Fractions
    Journal of Pharmaceutical Innovation, 22(1)
  2. Zhao L. (2027)
    An in silico evaluation of tri-allelic SNPs from 1kGP Phase IV data for distant kinship identification and mixture analysis
    Forensic Science International Genetics, 86
  3. Rana S.L. (2027)
    Ethnopharmacological validation of Capparis spinosa L. in gastrointestinal and respiratory disorders: Evidence from in vitro, in vivo, and in silico models
    Journal of Ethnopharmacology, 372

Article Details

How to Cite
Adillah, N., & Putra, A. (2026). Studi In Silico Senyawa Bioaktif Ekstrak Curcuma longa sebagai Inhibitor Protein LASR pada Bakteri Pseudomonas aeruginosa. MASALIQ, 6(5), 2565-2578. https://doi.org/10.58578/masaliq.v6i5.11687

References

Ahmad, I., Kuznetsov, A. E., Pirzada, A. S., Alsharif, K. F., Daglia, M., & Khan, H. (2023). Computational pharmacology and computational chemistry of 4-hydroxyisoleucine: Physicochemical, pharmacokinetic, and DFT-based approaches. Frontiers in Chemistry, 11, 1145974. https://doi.org/10.3389/fchem.2023.1145974

Chadha, J., Harjai, K., & Chhibber, S. (2022). Revisiting the virulence hallmarks of Pseudomonas aeruginosa: A chronicle through the perspective of quorum sensing. Environmental Microbiology, 24(6), 2630–2656. https://doi.org/10.1111/1462-2920.15784

Dai, C., Lin, J., Li, H., Shen, Z., Wang, Y., Velkov, T., & Shen, J. (2022). The natural product curcumin as an antibacterial agent: Current achievements and problems. Antioxidants, 11(3), 459. https://doi.org/10.3390/antiox11030459

Hakiki, A., Andika, A., & Rahmawati, R. (2024). Studi Molecular Docking dan Prediksi ADMET Senyawa Turunan Kurkumin sebagai Inhibitor Kasein Kinase 2-α. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 5(2), 195–212. https://doi.org/10.31764/lf.v5i2.22563

Hasan, R., Herowati, R., & Widodo, G. P. (2023). Molecular docking and pharmacokinetic prediction of potential compounds from Luffa acutangula as antidiabetic candidates. PHARMACY: Jurnal Farmasi Indonesia, 20(1), 71–76. https://doi.org/10.30595/pharmacy.v0i0.16066

Irwan, I., Hajrah, & Sastyarina, Y. (2021). Simulasi Docking Senyawa Napthoquinones Umbi Bawang Tiwai (Eleutherine americana Merr.) terhadap Bakteri Mycobacterium tuberculosis. Proceeding of Mulawarman Pharmaceuticals Conferences, 13(1), 92–98. https://doi.org/10.25026/mpc.v13i1.449

Jones, F., Hu, Y., & Coates, A. (2022). The efficacy of using combination therapy against multidrug- and extensively drug-resistant Pseudomonas aeruginosa in clinical settings. Antibiotics, 11(3), 323. https://doi.org/10.3390/antibiotics11030323

Martínez González, G., Falcón-González, J. M., García Contreras, R., Alvarado-Salazar, J. A., García Valdés, I., García Valdés, N., Lugo Gutiérrez, D. A., Bustamante Martínez, I. L., Tescucano Alonso, A. R., Ramírez-Villalva, A., & Almeida, J. A. (2026). Molecular insight into the inhibition of Pseudomonas aeruginosa quorum sensing by 5-bromoindole-3-carboxaldehyde and curcumin: A combined in vitro study, molecular dynamics, and docking studies. ACS Omega. Advance online publication. https://doi.org/10.1021/acsomega.6c02161

Pangastuti, A., Sari, S. L. A., Nugraheni, E. R., & Astuti, R. T. (2020). Inhibition of Pseudomonas aeruginosa virulence factors expression regulated by quorum sensing system using ethyl acetate extract of temu ireng (Curcuma aeruginosa). IOP Conference Series: Materials Science and Engineering, 858(1), 012031. https://doi.org/10.1088/1757-899X/858/1/012031

Praceka, M. S., Yunita, E. N., Semesta, C. D., Putri, R. N., Mikdar, N. N., Sitinjak, E. N., Setyawati, L. U., & Muchtaridi. (2022). Molecular docking and toxicity from temulawak rhizome (Curcuma xanthorrhiza Roxb.) against COX-2. Indonesian Journal of Pharmaceutical Science and Technology, 1(1), 106–115. https://doi.org/10.24198/ijpst.v1i1.43808

Prasad, S., Tyagi, A. K., & Aggarwal, B. B. (2014). Recent developments in delivery, bioavailability, absorption, and metabolism of curcumin: The golden pigment from golden spice. Cancer Research and Treatment, 46(1), 2–18. https://doi.org/10.4143/crt.2014.46.1.2

Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022). Pseudomonas aeruginosa: Pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances, and emerging therapeutics. Signal Transduction and Targeted Therapy, 7, 199. https://doi.org/10.1038/s41392-022-01056-1

Roskoski, R., Jr. (2019). Properties of FDA-approved small-molecule protein kinase inhibitors. Pharmacological Research, 144, 19–50. https://doi.org/10.1016/j.phrs.2019.03.006

Rowaiye, A. B., Mendes, Y. J. T., Olofinsae, S. A., Oche, J. B., Oladipo, O. H., Okpalefe, O. A., & Ogidigo, J. O. (2021). Camptothecin shows better promise than curcumin in the inhibition of the human telomerase: A computational study. Heliyon, 7(8), e07742. https://doi.org/10.1016/j.heliyon.2021.e07742

Saleh, M. M. (2022). Quorum sensing and some promising virulence inhibitors in Pseudomonas aeruginosa. Octahedron Drug Research, 1(1), 1–10. https://doi.org/10.21608/odr.2022.154964.1006

Simanullang, G., Rahayyu, A. M., Nabila, N. A., Hammami, A., & Wardani, I. K. (2025). Molecular docking and pharmacokinetic prediction of isoniazid and curcumin compounds against N-acetyltransferase 2 (NAT2) protein. Jurnal Ilmu Kefarmasian Indonesia, 23(2), 305–313. https://doi.org/10.35814/jifi.v23i2.1699

Tuon, F. F., Dantas, L. R., Suss, P. H., & Tasca Ribeiro, V. S. (2022). Pathogenesis of the Pseudomonas aeruginosa biofilm: A review. Pathogens, 11(3), 300. https://doi.org/10.3390/pathogens11030300

Urgancı, N. N., Yılmaz, N., Koçer Alaşalvar, G., & Yıldırım, Z. (2022). Pseudomonas aeruginosa and its pathogenicity. Turkish Journal of Agriculture–Food Science and Technology, 10(4), 726–738. https://doi.org/10.24925/turjaf.v10i4.726-738.4986

Yuliana, A., Rahmiyani, I., & Kartika, C. (2023). Molecular docking and molecular dynamics simulation using Monascus sp. as a candidate cervical cancer drug. Journal of Tropical Pharmacy and Chemistry, 7(1), 41–51. https://doi.org/10.25026/jtpc.v7i1.432

Yun, C.-I., Yang, H.-J., Lee, J.-H., & Kim, Y.-J. (2025). Validation, measurement uncertainty, and application of sesquiterpenoids and curcuminoids in turmeric (Curcuma longa L.) using HPLC-DAD and UHPLC-ESI-MS/MS. Food Science and Biotechnology, 34(3), 611–620. https://doi.org/10.1007/s10068-024-01677-y